Abeona Therapeutics Inc. (ABEO) Earnings History
Profitable31 years of earnings data (1995–2025) · Positive TTM net income
Loading earnings history...
Abeona Therapeutics Inc. (ABEO) Earnings Overview
As of June 23, 2026, Abeona Therapeutics Inc. (ABEO) reported trailing twelve-month net income of $66M, reflecting +165.2% year-over-year growth. The company earned $1.17 per diluted share over the past four quarters, with a net profit margin of 1223.1%.
Looking at the long-term picture, ABEO's historical earnings data spans multiple years. The company achieved its highest annual net income of $71M in fiscal 2025, representing a new all-time high.
Abeona Therapeutics Inc. maintains industry-leading profitability with a gross margin of 73.7%, operating margin of -1536.9%, and net margin of 1223.1%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including KRYS ($225M net income, 52.6% margin), RARE (-$609M net income, -85.4% margin), FOLD (-$27M net income, -4.3% margin), ABEO has outperformed on profitability metrics. Compare ABEO vs KRYS →
ABEO Earnings vs Peers
Earnings metrics vs comparable public companies
ABEO Historical Earnings Data (1995–2025)
31 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $71M | +211.7% | -$89M | $1.01 | 1223.1% | -1536.9% |
| 2024 | -$64M | -17.6% | -$64M | $-1.55 | - | - |
| 2023 | -$54M | -36.5% | -$47M | $-2.53 | -1548.2% | -1346.7% |
| 2022 | -$40M | +53.3% | -$51M | $-5.53 | -2807.4% | -3600.8% |
| 2021 | -$85M | -0.8% | -$90M | $-21.50 | -2831.2% | -2994.5% |
| 2020 | -$84M | -10.4% | -$81M | $-22.75 | -842.3% | -814.2% |
| 2019 | -$76M | -34.6% | -$77M | $-38.07 | - | - |
| 2018 | -$57M | -107.4% | -$58M | $-29.81 | -1890.3% | -1940.2% |
| 2017 | -$27M | -24.9% | -$28M | $-16.40 | -3263.9% | -3325.7% |
| 2016 | -$22M | -50.6% | -$24M | $-16.00 | -2460.4% | -2686.3% |
| 2015 | -$15M | +45.8% | -$19M | $-13.16 | -1396.7% | -1783.3% |
| 2014 | -$27M | -701.9% | -$3M | $-381.50 | -2894.9% | -338.5% |
| 2013 | $4M | +142.2% | -$4M | $76.00 | 217.9% | -186.3% |
| 2012 | -$11M | -316.0% | -$4M | $-650.00 | -239.1% | -98.0% |
| 2011 | -$3M | +66.4% | -$8M | $-275.00 | -137.0% | -426.2% |
| 2010 | -$8M | +56.5% | -$8M | $-750.00 | -1566.9% | -1612.7% |
| 2009 | -$17M | +44.8% | -$10M | $-2037.50 | -4926.1% | -2748.9% |
| 2008 | -$31M | -44.6% | -$17M | $-5200.00 | -10801.0% | -5812.7% |
| 2007 | -$22M | -68.9% | -$7M | $-12900.00 | -38147.4% | -12105.3% |
| 2006 | -$13M | -657.3% | -$5M | $-4557.17 | - | - |
| 2005 | -$2M | +83.4% | -$10M | $-656.62 | - | - |
| 2004 | -$10M | -47.6% | -$6M | $-4225.00 | -1864.8% | -1093.4% |
| 2003 | -$7M | +26.1% | -$5M | $-3262.50 | -535.5% | -419.0% |
| 2002 | -$9M | -55.7% | -$9M | $-4477.10 | -818.1% | -758.5% |
| 2001 | -$6M | -11.0% | -$6M | $-2930.00 | -2480.2% | -2595.9% |
| 2000 | -$5M | -64.1% | -$6M | $-3073.61 | -5072.9% | -5661.7% |
| 1999 | -$3M | +2.7% | -$3M | $-3396.30 | -22053.3% | -22326.7% |
| 1998 | -$3M | +23.4% | -$4M | $-6204.38 | -3400.0% | -3500.0% |
| 1997 | -$4M | +61.3% | -$5M | $-11102.50 | -1020.9% | -1040.0% |
| 1996 | -$11M | -3461.3% | -$12M | $-28655.00 | -6863.5% | -6953.9% |
| 1995 | $341,000 | - | $341,000 | $37888.00 | 11.6% | 11.6% |
Download Data
Export ABEO earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
31+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ABEO — Frequently Asked Questions
Quick answers to the most common questions about buying ABEO stock.
What is ABEO earnings per share (EPS)?
ABEO trailing twelve-month (TTM) diluted EPS is $1.17, reflecting +165.2% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1995 to 2025 is available in the table on this page.
What is Abeona Therapeutics Inc.'s net income?
Abeona Therapeutics Inc. (ABEO) trailing twelve-month net income is $66M as of 2025. Earnings grew +165.2% year-over-year.
Is ABEO profitable?
Yes, ABEO is profitable with a TTM net income of $66M and a net profit margin of +1223.1%.
What is ABEO's earnings growth rate?
ABEO compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1995 to 2025.
What are ABEO's profit margins?
Abeona Therapeutics Inc. net profit margin is +1223.1%, operating margin is -1536.9%, and gross margin is +73.7%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +70.0%.
Is ABEO growing earnings?
Yes, ABEO earnings are accelerating — EPS growth of +165.2% exceeds the 5-year CAGR of N/A. TTM net income reached $66M. Earnings momentum is strengthening.
What was ABEO's best earnings year?
Abeona Therapeutics Inc.'s highest annual net income on record is $71M, achieved in fiscal year 2025. Earnings history on this page spans 1995 to 2025 and includes all annual and quarterly figures.
What were ABEO's earnings last quarter?
ABEO's most recent reported quarter was Q1 2026. Net income was $-17M with diluted EPS of $-0.30. For a full breakdown of all quarters, see the quarterly earnings table on this page.